[Federal Register Volume 86, Number 23 (Friday, February 5, 2021)]
[Notices]
[Page 8381]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02455]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-772]


Bulk Manufacturer of Controlled Substances Application: Sterling 
Pharma USA, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sterling Pharma USA LLC has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 6, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 6, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 5, 2021, Sterling Pharma USA, LLC., 1001 
Sheldon Drive, Suite 101, Cary, North Carolina 27513-2078, applied to 
be registered as an bulk manufacturer of the following basic class(es) 
of controlled substance(s):

------------------------------------------------------------------------
                                            Drug
           Controlled substance             code         Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols....................   7370  I
------------------------------------------------------------------------

    The company plans to manufacture in bulk drug code 7370 
(Tetrahydrocannabinols) exclusively from hemp extract, for distribution 
and sale to its customers. No other activity for this drug code is 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02455 Filed 2-4-21; 8:45 am]
BILLING CODE P